USE OF A MARKER COMBINATION COMPRISING OSTEOPONTIN AND CARCINOEMBRYONIC ANTIGEN IN THE ASSESSMENT OF COLORECTAL CANCER

摘要

The present invention relates to a method aiding in the assessment of colorectal cancer (= CRC). It discloses the use of a marker combination comprising osteopontin and carcinoembryonic antigen in the assessment of colorectal cancer. Furthermore, it especially relates to a method for assessing colorectal cancer from a liquid sample, derived from an individual by measuring at least the markers osteopontin and carcinoembryonic antigen in said sample. The marker combination comprising osteopontin and carcinoembryonic antigen can, e.g., be used in the early detection of colorectal cancer or in the surveillance of patients who undergo therapy, e.g. surgery.